Dallas, TX -- (ReleaseWire) -- 07/07/2014 -- Increasing incidence of bleeding disorders across the globe has kept the global blood plasma market afloat and is likely to keep the momentum going on in near future as well. Major bleeding disorders, including Hemophilia A & B and Von Willebarnd disease, have been registering increasing number of patients across geographies which translates into expanding patient-base for the market. The industry has been on a transitional course wherein it is emerging from an industry deriving most of its revenues from the relatively smaller population of its traditional (read developed) markets to an industry witnessing a shift towards the emerging markets under similar perspective.
As per the report, “ Global Blood Plasma Market Report: 2014 Edition ” , rising healthcare expenditure, increasing penetration of plasma-derived products, ageing population, improving economic conditions and rising inclination of the developing world towards this industry, both in terms of rising demand and increasing domestic market access, have paved a concrete growth path for the industry. Furthermore, China still remains part of the unchartered waters that the industry hasn’t yet explored which adds to the optimism surrounding the future of the industry. However, increasing global fractionation capacities packed with already escalating price pressures and stricter regulation are likely to pose as the major hurdles on the same growth path.
This report presents an exhaustive study of the blood plasma market elucidating global market dynamics with an eye on major segments of the same. Major consumer countries of various plasma-proteins have also been discussed to complete the demand side of the industry. The report shines light on the major players that are shaping the industry: their market standing and business strategies against the backdrop of overall competitive landscape of the industry which have also been presented.
The report also encompasses the major trends, growth drivers as well as issues being faced by the global industry. Recent as well as future developments affecting the industry have also been presented. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction in terms of value of the industry has also been analyzed in the report.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=344976.
Major points from Table of Contents (http://www.marketreportsonline.com/344976-toc.html) are listed below:
List of Tables
Constituents of Blood Plasma
Recovered plasma vs. Source plasma
Output per Liter of Plasma
US Medicare IG Reimbursement Rates
Long Acting FIX & FVIII under Late-Stage Development
Extended Half Life rFVIII Agents
Extended Half Life rFIX Agents
Global Fractionation Capacity and Throughput, 2014E
New Patient Registrations in the Worldwide Bleeding Disorders Market (2008-2013E)
Global Availability of NMEs (2012)
rFVIII Product Pipeline
Global Plasma Product Sales by Company (2010-2013)
Global Ig Sales by Company (2010-2013)
Dependent & Independent Variables (2007-2013)
Model Summary - Coefficient of Determination
Regression Coefficients Output
Related Report on Medical Devices Market:
Global Endoscopy Market Report: 2014 Edition (http://www.marketreportsonline.com/322284.html) The development of technologically advanced endoscopic equipments in the US, Europe and Japan has resulted in steep market growth of endoscopic products in these regions, while diffusion of these products in emerging countries like China and India has just started. However, these emerging economies hold great opportunities for endoscopy market growth due to increasing income levels and improving medical infrastructure.
Contact firstname.lastname@example.org for further information/ details.